Sanofi's distribution deals; AstraZeneca to supply US and China independently; Merck KGaA expands in China
28 Mar 2024
VaccineClinical Study
Welcome to Endpoints News’ manufacturing briefs, where we bring you essential updates on new builds, collaborations, recalls and more.
Sanofi has secured three deals this week to supply its medicines in India and Korea. On Wednesday, Dr Reddy Laboratories announced it will distribute seven of Sanofi’s vaccines in India, a day after Indian manufacturer Cipla said it will locally distribute six of Sanofi’s central nervous system products. Also on Tuesday, Sanofi unveiled a partnership with SK Bioscience to distribute five of its vaccines in Korea.
Preview
Source: EndPoints
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
SIGN UP
LOG IN
BECOME A PREMIUM SUBSCRIBER
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.